Sensei Biotherapeutics, Inc. - COM (SNSE)

CUSIP: 81728A108

Q1 2024 13F Holders as of 31 Mar 2024

Share change
-652,931
SEC-reported price per share
$1.05
Number of holders
24
Value change
-$649,432
Number of buys
6
Number of sells
7

Security key

81728A108

Report period

Q1 2024

Institutions

24

Top holders

10

Ownership snapshot

Top reported holders of SNSE - Sensei Biotherapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Newtyn Management, LLC
Disclosed value leader
Newtyn Management, LLC
Comparable rows
0/15
Latest evidence
15 Feb 2024
13F 3/4/5 Highest disclosed value: $1,087,840 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Newtyn Management, LLC has the largest disclosed position value at $1.09M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Newtyn Management, LLC's linked filing trail.
Disclosed position value Top 5
Newtyn Management, LLC $1.09M
VANGUARD GROUP INC $397K
RENAISSANCE TECHNOLOGIES LLC $99K
GEODE CAPITAL MANAGEMENT, LLC $94.4K
Robert Hamilton Pierce $80.3K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Newtyn Management, LLC
13F
Company
13F
class O/S missing
$1,087,840
1,572,023 shares
31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
class O/S missing
$396,966
573,651 shares
31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
class O/S missing
$99,000
143,508 shares
31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
class O/S missing
$94,350
136,318 shares
31 Dec 2023
Robert Hamilton Pierce
3/4/5
Chief R&D Officer
class O/S missing
$80,294
94,463 shares
15 Feb 2022
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
13F
class O/S missing
$78,127
112,900 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
24
Shares
2,309,379
Rows available
24
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
24
Q1 2024 holders
24
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .